Jonathan M. Peacock, President and CEO at Bellerophon Therapeutics, Inc. (BLPH), bought 5,000 shares at $1.37 ($7K) on 2016-05-17, disclosed to the SEC on 2016-05-18.
Open-market purchase of $7k BLPH by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| BLPH | BUY | 2019-01-25 | $1.0M | — | Filing → |
| BLPH | BUY | 2015-12-17 | $56K | — | Filing → |
| BLPH | BUY | 2015-08-20 | $27K | — | Filing → |